Ray had plenty of time to find a partner for Tesetaxel since the failure of Genasense. Instead, shareholders got screwed once more. FINRA has sent a message to RAy and cronies that the game is over. Unfortunately, it might be over for shareholders as well. It all depends if Ray can pull a rabbit out of his hat.